Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. MacLaren R, Sullivan PW. Value Health. 2005 Mar-Apr;8(2):105-16. PMID: 15804319 https://pubmed.ncbi.nlm.nih.gov/15804319/ Like Tweet +1